A new bipartisan bill in Congress, the End Kidney Deaths Act, aims to combat the national kidney shortage by offering financial incentives to living kidney donors. The proposed legislation would provide a refundable tax credit of $10,000 annually for five years to individuals who donate a kidney to a stranger, in hopes of encouraging more people to participate in life-saving organ donation.
Sally Satel, a Yale School of Medicine lecturer and two-time kidney recipient, is one of the most vocal proponents of the bill. In a recent interview, she shared her own story of being saved by two unrelated donors and argued that altruism alone is not meeting the urgent demand. With nearly 100,000 Americans currently on the kidney transplant waitlist and 12 dying each day due to the shortage, Satel believes compensation could help close the gap while still preserving the altruistic spirit of donation.
The National Organ Transplant Act of 1984 currently prohibits payment for organs, upholding a strict commitment to voluntary donation. Satel and supporters of the new bill emphasize that the proposed tax credits are not lump-sum cash payments, but structured, delayed benefits that avoid exploiting vulnerable populations. The donation process would remain rigorous, requiring months of screening and informed consent.
Critics argue that any form of payment could exploit low-income individuals or worsen black markets, but Satel counters that a regulated, transparent system would actually eliminate underground practices. She also points to the economic benefits: Medicare currently spends over $80,000 per dialysis patient annually, with dialysis accounting for 5% of all Medicare spending despite serving less than 1% of enrollees.
